Paras Biopharmaceuticals Finland Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Paras Biopharmaceuticals Finland General Information

Description

Developer of biopharmaceutical technology designed for enhanced biologics or biosimilar production. The company platform develops products such as long-acting insulin, osteoporosis, rheumatoid arthritis, and oncology products, as well as recombinant bioprocess enzymes, enabling pharma companies to employ combined unique expertise to perform cleavage of proteins with a fusion partner that eliminates the need to use expensive cleavage enzymes in the production of a product.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Kiviharjunlenkki 10
  • 90220 Oulu
  • Finland
+358 044
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • Kiviharjunlenkki 10
  • 90220 Oulu
  • Finland
+358 044

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Paras Biopharmaceuticals Finland Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 17-Feb-2022 Completed Generating Revenue
1. Corporate 25-Aug-2016 Completed Generating Revenue
To view Paras Biopharmaceuticals Finland’s complete valuation and funding history, request access »

Paras Biopharmaceuticals Finland Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biopharmaceutical technology designed for enhanced biologics or biosimilar production. The company platform
Biotechnology
Oulu, Finland
11 As of 2026

Hilden, Germany
 

Turku, Finland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Paras Biopharmaceuticals Finland Competitors (3)

One of Paras Biopharmaceuticals Finland’s 3 competitors is Qiagen, a Formerly VC-backed company based in Hilden, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Qiagen Formerly VC-backed Hilden, Germany
3PBiovian Private Equity-Backed Turku, Finland
Savara Formerly VC-backed Yardley, PA
You’re viewing 3 of 3 competitors. Get the full list »

Paras Biopharmaceuticals Finland Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Paras Biopharmaceuticals Finland Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kasvu Open Not-For-Profit Venture Capital
ASAP Growth Corporation Minority
To view Paras Biopharmaceuticals Finland’s complete investors history, request access »

Paras Biopharmaceuticals Finland FAQs

  • When was Paras Biopharmaceuticals Finland founded?

    Paras Biopharmaceuticals Finland was founded in 2012.

  • Where is Paras Biopharmaceuticals Finland headquartered?

    Paras Biopharmaceuticals Finland is headquartered in Oulu, Finland.

  • What is the size of Paras Biopharmaceuticals Finland?

    Paras Biopharmaceuticals Finland has 11 total employees.

  • What industry is Paras Biopharmaceuticals Finland in?

    Paras Biopharmaceuticals Finland’s primary industry is Biotechnology.

  • Is Paras Biopharmaceuticals Finland a private or public company?

    Paras Biopharmaceuticals Finland is a Private company.

  • What is Paras Biopharmaceuticals Finland’s current revenue?

    The current revenue for Paras Biopharmaceuticals Finland is .

  • How much funding has Paras Biopharmaceuticals Finland raised over time?

    Paras Biopharmaceuticals Finland has raised $17.9M.

  • Who are Paras Biopharmaceuticals Finland’s investors?

    Kasvu Open and ASAP Growth have invested in Paras Biopharmaceuticals Finland.

  • Who are Paras Biopharmaceuticals Finland’s competitors?

    Qiagen, 3PBiovian, and Savara are competitors of Paras Biopharmaceuticals Finland.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process